About us

C.E.L.forpharma stands for “Centre for Executive Leadership for the pharmaceutical industry” and has been created in January 2005 to offer a range of international special-topics training services with the support of reputable pharma industry expert-consultants and organizations.
On this page you can find information about the history and the people behind C.E.L.forpharma:

History

Founders

Staff

Experts

Partners

History

• Foundation.
• Launch of the Business Development course with Martin Austin.
• Launch of the Lifecycle Management course with Neal Hansen.
• Launch of a series of therapy market focused seminars in collaboration with Datamonitor Healthcare, starting with the following areas: Oncology – COX2 – Respiratory Diseases.
  

• Launch of the Brand Planning course with Edouard Demeire.
• Launch of the Marketing Excellence & Salesforce Effectiveness course with Edouard Demeire.
• Therapy area seminars organized with Datamonitor in 2006: Oncology – Metabolic Syndrome – Respiratory Diseases.

• Launch of the Forecasting course with Gary Johnson.
• Launch of the Valuation course with Patrik Frei.
• The Test Your Brand Planning Know-How tool offered on our website
• Therapy area seminars organized with Datamonitor in 2007: CNS – Diabetes.

• The Brand Plan Quality Checklist offered on our website.
• Launch of the Pricing course with Gary Johnson.
• Launch of the Market Access course with the Adelphi Group.
• Launch of the Pearls of Wisdom newsletter.
• Therapy area seminars organized with Datamonitor in 2008: Diabetes – Pain – Infectious Diseases.
  

Founders

Edouard Demeire,

Managing Partner

• His teaching, consulting and research focus is on systematic decision support tools and models for pharma marketing strategy.
• Trained over 4000 executives in the pharmaceutical industry, all over the globe.
• Numerous in-house assignments for pharma companies: Roche, AZ, J&J, Novartis, Lilly, UCB, Schering-Plough, etc.
• Developed the very successful STRATPHARM business simulation game in collaboration with Prof. Marcel Corstjens of INSEAD.
• Visiting Professor at several business schools: CEDEP (INSEAD) in Fontainebleau, Solvay Business School in Brussels, SIMI in Denmark, Management Center Europe (MCE) in Belgium, etc.
• Master degree in econometrics from the university of Antwerp.

Luc De Langhe,

Managing Director

• Creative entrepreneurial executive with over 25 years of experience within the European pharmaceutical industry sector.
• Vice President Europe with US-based Decision Resources, a reputable business intelligence firm for the life science industries.
• Programme Director with Management Centre Europe (MCE), a well-known international management development organization.
• Held several sales and marketing positions at Ciba-Geigy (now Novartis) and Eli Lilly in their Brussels offices.
• Masters degrees in engineering and management science from the universities of Brussels and Leuven.

Staff

Marie Stricklesse

Programme Coordinator

Marie is responsible for the flawless organization of all our courses and seminars. She coordinates all the activities that result in a well-organized training experience for the participants. She is the point of contact for our participants as well as for the expert faculty, hotels and other suppliers we work with.
Marie has a Master in Translation and speaks fluently Dutch, English, French and Spanish.

Annelies Swaan

Client Relationship Associate

Annelies is responsible for establishing and building strong and lasting relationships with our client companies. She is involved in communication and account management projects that must ensure we develop mutually beneficial relationships with our clients.
Annelies has a Master in Translation and speaks fluently Dutch, English, French and Spanish.

Experts

Edouard Demeire

Managing Director, Prism

Edouard Demeire uniquely combines in-depth pharma marketing expertise with academic rigour and a wealth of training experience all over the globe. His teaching, consulting and research focus is on systematic decision support tools and models for pharma marketing strategy. He developed the very successful STRATPHARM business simulation game in collaboration with Prof. Marcel Corstjens of INSEAD.
Edouard has trained well over 4000 executives in the pharmaceutical industry. He is a Visiting Professor at CEDEP (INSEAD) in Fontainebleau, Solvay Business School in Brussels, SIMI in Copenhagen, and until recently at Management Centre Europe (MCE). In addition, he trains and consults for Roche and AZ and has worked on numerous assignments for companies such as J&J, Novartis, Lilly, etc. Edouard holds a degree in Econometrics from the University of Antwerp.

Martin Austin

Managing Director, TransformRX
Author of "Business Development for the Biotechnology and Pharmaceutical Indurstry"

Martin Austin has a strong reputation in Europe’s senior (bio)pharma business development community. His profile uniquely combines the expertise and experience of a high profile pharma business development executive with that of a senior life science capital investment officer. Between 1996 and 2000, Martin was Roche’s global Head of Business Development for Pharmaceuticals. During that period he had a leading role in the establishment of Roche Genetics, the rationalisation of the R&D portfolio which led to the establishment of Actelion, Basilea and BioXell, as well as in the acquisition and integration of Boehringer Mannheim. After that, until January 2005, he was a Principal with Paul Capital Partners, a global private equity firm, leading their European Royalty healthcare activities. In 2005, Martin founded TransformRx to provide business advice to clients regarding investment and business development opportunities. Martin is also a faculty member of the “European Course for BioBusiness Development” at the University of Basel.

Gary Johnson

Founder and CEO of Inpharmation
Author of "Sales Forecasting for Pharmaceuticals: An Evidence Based Approach"

As the founder and Managing Director of Inpharmation, a consultancy specialising in pharma forecasting and modelling, Gary Johnson works with the world's top 10 pharma companies and many more.
Prior to founding Inpharmation, Gary spent two decades in the pharma industry holding senior positions, such as General Manager and Head of Global Marketing with a number of major blue-chip pharma companies, including SmithKline Beecham, Fisons and Schwarz. Gary Johnson is a sought-after industry speaker and conference chairman. Winner of a number of speaking and best paper awards with the EphMRA and the BHBIA, he is the author of Evidence Based Forecasting for Pharmaceuticals - the definitive work on forecasting (and influencing) the sales of pharmaceutical products. Other books include Monkey Business: Why the Way You Manage is a Million Years out of Date - finalist for the MCA Book Prize.

Lloyd Morgan

General Manager, Adelphi Group Ltd

Lloyd Morgan is the General Manager of Adelphi Group. Lloyd has worked with Adelphi for over 19 years and has experience in communications, outcomes and marketing research. He is a member   of Adelphi’s pricing consultancy team. Lloyd originally trained as an accountant and his previous experience included involvement in the European launch of Tenormin when working with AstraZeneca. Lloyd is    a member of the Market Research Society

Zoë Philips

Research Director, Mapi Values

Zoë Philips is a Research Director with Mapi Values. Her role involves the research and assimilation of value data and evidence generation to create communication strategies to achieve optimal market uptake and reimbursement of products. Zoë’s background is in health economics, with specific knowledge of the UK market. She has worked closely with NICE and the NCCHTA program in developing methodology for decision modelling. She has worked as part of the Technology Assessment Review Team from the University of York, where her role involved reviewing and appraising company submissions to NICE and in developing tools to support NICE decisions. Zoë has worked both in academia and pharma industry. She brings direct knowledge of the market access issues facing the industry and of the rapidly developing Heath Technology Assessment requirements of agencies across the globe.

Dr. Patrik Frei

Founder and CEO of Venture Valuation AG
Author of "Assessment and valuation of high growth companies"

Dr. Patrik Frei is founder and CEO of Venture Valuation AG, Switzerland. Venture Valuation specializes in independent, third party assessment and valuation of emerging high growth companies in biotechnology and life sciences. Services are provided in the form of proprietary Valuation Reports(TM) to companies and investors. Furthermore, Venture Valuation runs the Biotech and Life Sciences Databases Biotechgate and other country databases in Austria, Canada, France, Germany, India, Italy and Switzerland.
Patrik graduated from the Business University of St. Gall and wrote his doctoral thesis “Assessment and valuation of high growth companies” at the Swiss Federal Institute of Technology, EPFL Lausanne. His previous occupations include CFO of a trucking company; training at several international corporations: LeCroy (Geneva, New York), Hans Merensky Holding (South Africa), Swatch Group - EM Microelectronic (Marin).

Dr. Neal Hansen

Global Director of Consulting, Datamonitor Healthcare

Neal is the Global Director of Datamonitor’s Healthcare Consulting Practice. In this role, he leads a multi-disciplinary team focusing on the provision of customized solutions to leading players in the pharmaceutical and biotechnology industries in key areas such as portfolio and brand management, in- and out-licensing and forecasting.
Prior to this role, Neal was the European Head of Consulting within Wood Mackenzie’s Life Sciences Practice. During his time at Wood Mackenzie, Neal led commercial assessment, scenario planning and war gaming projects for numerous top tier and mid-cap pharmaceutical companies in Europe, the US and Japan. Earlier in his career, Neal held various senior roles within Datamonitor including Lead Consultant and Lead Analyst for Strategic and Company Intelligence encompassing Strategic Insight, eHealthInsight and PharmaVitae Company Tracking.
He has authored in-depth analysis on strategic issues affecting the pharmaceutical industry, focusing on lifecycle management, pharmaceutical sales force strategies, competitive dynamics in mature and emerging markets and the changing nature of the global generics sector. He has chaired a spoken at numerous conferences in the field of lifecycle management and the changing nature of the generics industry. His work has featured in In Vivo, The Economist, The Wall Street Journal, MedAd News and PharmaFocus.
Neal holds a PhD in Pharmacology (University of Cambridge), and a MA in Natural Sciences (University of Cambridge).

Partners

We work with Datamonitor Healthcare since our foundation, and in particular with their senior therapy area analysts and senior consultants. All the therapy area seminars, as well as the lifecycle management seminar, have been developed and delivered by their team, with great success.